Hematology Oncology

Pioneering Pediatric Hematology and Oncology Care

• A nationally-recognized leader in pediatric oncology. As part of the Children’s Oncology Group (COG)and multiple national and regional clinical trial networks, we have access to some of the newest emerging clinical trials and specialized hematology and oncology treatments available.
• We participate and lead bold new therapies including curative gene therapy for inherited blood disorders such as Thalassemia and Sickle Cell disease.
• The programs in Thalassemia, Sickle Cell disease and Blood and Marrow Transplant lead clinical trial networks nationally and internationally.
• Our program seeks opportunities to lead and collaborate in multi-center research to foster the advancement of new diagnostic and intervention therapies.
• Our 25-bed inpatient Hematology Oncology Transplant unit is air-controlled to protect our immune-suppressed patients. The transplant unit also has its own playroom and schoolroom that may be used by your child during treatment. There are private, air-filtered isolation rooms for children staying with us long-term.
• Outpatient transfusion and chemotherapy services are provided via a 20-bed day-use unit.

Multidisciplinary Care

• Every child who comes through our doors gets personalized attention from our team of professionals. From the attending board-certified hematologist-oncologist who oversees our department to the individual specialist physician assigned to each patient, we take a team approach that ensures your child receives the best care possible.
• Many of our programs have multi-disciplinary clinics to enhance the care each patient receives, understanding that a team approach better serves the medical and logistical needs of our patients. Patients and families that attend these clinics can expect to be seen by multiple physician specialists and other critical members of the team that attend to all their medical needs as well as emotional, social and financial needs.
• Our Hematology Oncology Program includes a multidisciplinary Tumor Board comprised of oncologists, surgeons, pathologists, radiologists, radiation oncologists and bone marrow transplant specialists who come together weekly to discuss each child's individual case and develop a specialized treatment plan tailored to each child’s unique situation.